Correction
This article was originally published in The Gray Sheet
Executive Summary
A story in the Aug. 27 issue erroneously referred to a patent reform bill (H.R. 1908) as "House-approved" (1"The Gray Sheet" Aug. 27, 2007, p. 3). The bill cleared the House Judiciary Committee, but has not yet been put to a vote on the House floor...
You may also be interested in...
Patent Rule Limits Applications, Impacting Device Makers’ Filing Strategies
A highly anticipated final 1rule from the U.S. Patent and Trademark Office puts new limits on the number of applications a company can file for any single invention, potentially requiring changes in device manufacturers' patent strategies
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.